Ledger.Open graph →
SEC Form D · filed July 30, 2024

SEELOS THERAPEUTICS, INC

Offering
$1.1M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

William Dorsey · Parsippany, NJExecMark Levine · Washington D.C., Washington, D.C.ExecParas Malde · Camana Bay, Grand Cayman, Cayman IslandsDirectorMargaret W. Dalesandro · New York, NYDirectorRichard Smith · Orem, UTDirectorMichael W. Golembiewski · New York, NYExecRichard W. Pascoe · New York, NYDirectorMargot Lyons · Dublin, IrelandExecMichael W. Golembiewski · New York, NYExecSylvester O'Byrne · Dublin, IrelandDirectorRaj Mehra · New York, NYExecMargaret W. Dalesandro · New York, NYDirectorRiyas Nooruddin · Camana Bay, Grand Cayman, Cayman IslandsDirectorKent Gordon · Salt Lake City, UTDirectorBrian Lian · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗